LifeTech Scientific (FRA:81X) Research & Development: €29.4 Mil (TTM As of Dec. 2025)


FRA:81X LifeTech Scientific Corp FRA:81X
96 GF Score
Price €0.14
GF Value €0.21
! 4 Warning Signs
View Full Analysis

What is LifeTech Scientific Research & Development?

LifeTech Scientific FRA:81X -0.71% 96 Research & Development is €29.4 Mil as of Dec. 2025. GuruFocus rates FRA:81X with a GF Score™ of 96/100 and a GF Value™ of €0.21. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. LifeTech Scientific's Research & Development for the six months ended in Dec. 2025 was €15.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €29.4 Mil.

LifeTech Scientific  (FRA:81X) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

LifeTech Scientific Research & Development Related Terms

LifeTech Scientific Research & Development Historical Data

* Premium members only.

The historical data trend for LifeTech Scientific's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeTech Scientific Research & Development Chart

LifeTech Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.27 28.23 38.26 39.73 29.42

LifeTech Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.06 17.92 21.38 13.82 15.54
FRA:81X
96GF Score
LifeTech Scientific Corp FRA:81X
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeTech Scientific Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €29.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €29.4 Mil mean?
LifeTech Scientific (FRA:81X) has a Research & Development of €29.4 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on LifeTech Scientific and its competitors.
Is LifeTech Scientific's Research & Development too high?
LifeTech Scientific's current Research & Development is €29.4 Mil. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's Research & Development compare to ABT and SYK?
LifeTech Scientific's Research & Development of €29.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on LifeTech Scientific and its competitors. LifeTech Scientific's current Research & Development is €29.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (FRA:81X) has a current Research & Development of €29.4 Mil. The stock's GF Value™ is €0.21, compared to a current price of €0.14 — trading 33.3% below its estimated fair value. The current Research & Development is €29.4 Mil. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For LifeTech Scientific (FRA:81X), the current Research & Development is €29.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeTech Scientific (FRA:81X) Overvalued in 2026?

Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued. The current stock price of €0.14 is trading 33.3% below its estimated GF Value™ of €0.21.

Key valuation signals for FRA:81X:

  • Research & Development: €29.4 Mil
  • GF Value™: €0.21 vs. price of €0.14 (33.3% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the FRA:81X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LifeTech Scientific Business Description

Other Exchanges 01302:Hong Kong
Address No. 22, Keji 12th Road South, 14th Floor, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score

Get the complete analysis for FRA:81X

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price
€0.21
GF Value